180 related articles for article (PubMed ID: 16468490)
1. Clinical experience with the effectiveness and tolerability of hylan G-F 20 in 1047 patients with osteoarthritis of the knee.
Waddell DD; Bricker DC
J Knee Surg; 2006 Jan; 19(1):19-27. PubMed ID: 16468490
[TBL] [Abstract][Full Text] [Related]
2. Tolerability and short-term effectiveness of hylan G-F 20 in 4253 patients with osteoarthritis of the knee in clinical practice.
Kemper F; Gebhardt U; Meng T; Murray C
Curr Med Res Opin; 2005 Aug; 21(8):1261-9. PubMed ID: 16083536
[TBL] [Abstract][Full Text] [Related]
3. Corticosteroid compared with hyaluronic acid injections for the treatment of osteoarthritis of the knee. A prospective, randomized trial.
Leopold SS; Redd BB; Warme WJ; Wehrle PA; Pettis PD; Shott S
J Bone Joint Surg Am; 2003 Jul; 85(7):1197-203. PubMed ID: 12851342
[TBL] [Abstract][Full Text] [Related]
4. An open-label study of a second course of hylan G-F 20 for the treatment of pain associated with knee osteoarthritis.
Waddell DD; Cefalu CA; Bricker DC
Curr Med Res Opin; 2003; 19(6):499-507. PubMed ID: 14594522
[TBL] [Abstract][Full Text] [Related]
5. Intra-Articular, Single-Shot Hylan G-F 20 Hyaluronic Acid Injection Compared with Corticosteroid in Knee Osteoarthritis: A Double-Blind, Randomized Controlled Trial.
Tammachote N; Kanitnate S; Yakumpor T; Panichkul P
J Bone Joint Surg Am; 2016 Jun; 98(11):885-92. PubMed ID: 27252432
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of hylan G-F 20 injection in treatment of knee osteoarthritis in Chinese patients: results of a prospective, multicentre, longitudinal study.
Yan CH; Chan WL; Yuen WH; Yung PS; Ip KY; Fan JC; Chiu KY
Hong Kong Med J; 2015 Aug; 21(4):327-32. PubMed ID: 26087755
[TBL] [Abstract][Full Text] [Related]
7. Viscosupplementation with hylan G-F 20 (Synvisc): pain and mobility observations from 74 consecutive patients.
Lee S; Park D; Chmell SJ
J Knee Surg; 2004 Apr; 17(2):73-7. PubMed ID: 15124659
[TBL] [Abstract][Full Text] [Related]
8. Intra-articular hylan G-F 20 (Synvisc) in the management of patellofemoral osteoarthritis of the knee (POAK).
Clarke S; Lock V; Duddy J; Sharif M; Newman JH; Kirwan JR
Knee; 2005 Jan; 12(1):57-62. PubMed ID: 15664879
[TBL] [Abstract][Full Text] [Related]
9. Multicentre, prospective, open study to evaluate the safety and efficacy of hylan G-F 20 in knee osteoarthritis subjects presenting with pain following arthroscopic meniscectomy.
Huskin JP; Vandekerckhove B; Delincé P; Verdonk R; Dubuc JE; Willems S; Hardy P; Blanco FJ; Charrois O; Handelberg F
Knee Surg Sports Traumatol Arthrosc; 2008 Aug; 16(8):747-52. PubMed ID: 18536906
[TBL] [Abstract][Full Text] [Related]
10. Intra-articular administration of hylan G-F 20 in patients with symptomatic hip osteoarthritis: tolerability and effectiveness in a large cohort study in clinical practice.
Migliore A; Tormenta S; Massafra U; Bizzi E; Iannessi F; Alimonti A; Granata M
Curr Med Res Opin; 2008 May; 24(5):1309-16. PubMed ID: 18373891
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of Hylan G-F 20 and Sodium Hyaluronate in the treatment of osteoarthritis of the knee -- a prospective randomized clinical trial.
Raman R; Dutta A; Day N; Sharma HK; Shaw CJ; Johnson GV
Knee; 2008 Aug; 15(4):318-24. PubMed ID: 18430574
[TBL] [Abstract][Full Text] [Related]
12. Hylan G-F 20 Versus Low Molecular Weight Hyaluronic Acids for Knee Osteoarthritis: A Meta-Analysis.
Zhao H; Liu H; Liang X; Li Y; Wang J; Liu C
BioDrugs; 2016 Oct; 30(5):387-396. PubMed ID: 27435213
[TBL] [Abstract][Full Text] [Related]
13. The use of hylan G-F 20 after knee arthroscopy in an active patient population with knee osteoarthritis.
Zietz PM; Selesnick H
Arthroscopy; 2008 Apr; 24(4):416-22. PubMed ID: 18375273
[TBL] [Abstract][Full Text] [Related]
14. Hylan G-F 20 tolerability with repeat treatment in a large orthopedic practice: a retrospective review.
Waddell DD; Bricker DC
J Surg Orthop Adv; 2006; 15(1):53-9. PubMed ID: 16603113
[TBL] [Abstract][Full Text] [Related]
15. The role of elastoviscosity in the efficacy of viscosupplementation for osteoarthritis of the knee: a comparison of hylan G-F 20 and a lower-molecular-weight hyaluronan.
Wobig M; Bach G; Beks P; Dickhut A; Runzheimer J; Schwieger G; Vetter G; Balazs E
Clin Ther; 1999 Sep; 21(9):1549-62. PubMed ID: 10509850
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness and safety of repeat courses of hylan G-F 20 in patients with knee osteoarthritis.
Raynauld JP; Goldsmith CH; Bellamy N; Torrance GW; Polisson R; Belovich D; Pericak D; Tugwell P
Osteoarthritis Cartilage; 2005 Feb; 13(2):111-9. PubMed ID: 15694572
[TBL] [Abstract][Full Text] [Related]
17. A second course of hylan G-F 20 for the treatment of osteoarthritic knee pain: 12-month patient follow-up.
Waddell DD; Cefalu CA; Bricker DC
J Knee Surg; 2005 Jan; 18(1):7-15. PubMed ID: 15742592
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and Safety of Hylan versus Hyaluronic Acid in the Treatment of Knee Osteoarthritis.
Dai WL; Lin ZM; Guo DH; Shi ZJ; Wang J
J Knee Surg; 2019 Mar; 32(3):259-268. PubMed ID: 29618143
[TBL] [Abstract][Full Text] [Related]
19. Total knee replacement delayed with Hylan G-F 20 use in patients with grade IV osteoarthritis.
Waddell DD; Bricker DC
J Manag Care Pharm; 2007 Mar; 13(2):113-121. PubMed ID: 17330972
[TBL] [Abstract][Full Text] [Related]
20. A prospective randomised controlled clinical trial comparing the efficacy of different molecular weight hyaluronan solutions in the treatment of knee osteoarthritis.
Kotevoglu N; Iyibozkurt PC; Hiz O; Toktas H; Kuran B
Rheumatol Int; 2006 Feb; 26(4):325-30. PubMed ID: 15959784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
